|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/68 | (2017.01) |
| A61K 39/39 | (2013.01) | ||
| A61K 39/39 | (2006.01) | ||
| A61K 47/6849 | (2017.08) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 47/6855 | (2017.08) | ||
| A61P 35/02 | (2006.01) | ||
| A61K 31/4745 | (2013.01) | ||
| A61P 35/04 | (2006.01) | ||
| A61K 47/6803 | (2017.08) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61P 35/04 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Number of the document | 2874651 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13820359.1 |
| Date of filing the European patent application | 2013-07-16 | |
| (97) | Date of publication of the European application | 2015-05-27 |
| (45) | Date of publication and mention of the grant of the patent | 2023-05-24 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CN2013/079441 |
| Date | 2013-07-16 |
| (87) | Number | WO 2014/012479 |
| Date | 2014-01-23 |
| (30) | Number | Date | Country code |
| 201210248481 | 2012-07-18 | CN |
| (72) |
LI, Lixin , CN
|
| (73) |
Birdie Biopharmaceuticals Inc. ,
4th Floor, Harbour Place
103 South Church Street
P.O. Box 10240, Grand Cayman, KY1-1002,
KY
|
| (54) | COMPOUNDS FOR TARGETED IMMUNOTHERAPY |
| COMPOUNDS FOR TARGETED IMMUNOTHERAPY |